Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Federal Trade Commission
Daiichi Sankyo
Cerilliant
Farmers Insurance
Teva
Chubb
Fish and Richardson

Generated: May 23, 2018

DrugPatentWatch Database Preview

THALITONE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Thalitone, and when can generic versions of Thalitone launch?

Thalitone is a drug marketed by Casper Pharma Llc and Monarch Pharms and is included in two NDAs.

The generic ingredient in THALITONE is chlorthalidone. There are nineteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
Drug patent expirations by year for THALITONE
Pharmacology for THALITONE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for THALITONE
Synonyms for THALITONE
(.+/-.)-Chlorthalidone
(.+/-.)-Hygroton
(+-)-Chlorthalidone
(+-)-Hygroton
036C257
1-Keto-3-(3'-sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline
1-Oxo-3-(3-sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline
2-Chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide
2-Chloro-5-(1-hydroxy-3-oxo-1H-isoindolinyl)benzenesulfonamide
2-chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)benzene-1-sulfonamide
2-Chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)benzenesulfonamide
2-Chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)benzenesulfonamide #
2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide
2-chloro-5-(1-hydroxy-3-oxo-isoindolin-1-yl)benzenesulfonamide
2-Chloro-5-(1-hydroxy-3-oxoisoindolin-1-yl)benzenesulfonamide
2-chloro-5-(1-hydroxy-3-oxoisoindolinyl)benzenesulfonamide
2-chloro-5-(1,3-dihydroxy-1H-isoindol-1-yl)benzene-1-sulfonamide
2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide
2-Chloro-5(1-hydroxy-3-oxo-1-isoindolinyl) benzenesulfonamide
3-(4'-Chloro-3'-sulfamoylphenyl)-3-hydroxyphthalimidine
3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine
4CH-007156
5-22-07-00602 (Beilstein Handbook Reference)
77-36-1
A3836/0162845
AB00051946
AB00051946_12
AB0007445
AC-11367
AC1L1ECB
AC1Q558X
AK116459
AKOS005599810
AN-23909
API0001976
AX8121003
BDBM25900
Benzenesulfonamide, 2-chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)-
Benzenesulfonamide, 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-
Benzenesulfonamide,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-
BPBio1_000487
BRD-A26384407-001-05-3
BRN 0312295
BSPBio_000441
BSPBio_002017
C-20285
C14H11ClN2O4S
CAS-77-36-1
CC-25734
CCG-38917
CHEBI:3654
CHEMBL1055
Chlorothalidone
Chlorphthalidolone
Chlorphthalidone
Chlortalidone
Chlortalidone (JAN/INN)
Chlortalidone 1.0 mg/ml in Methanol
Chlortalidone for peak identification, European Pharmacopoeia (EP) Reference Standard
Chlortalidonum
Chlortalidonum [INN-Latin]
Chlorthalidon
chlorthalidone
Chlorthalidone (Chlortalidone)
Chlorthalidone (USP)
Chlorthalidone [USAN:INN:BAN]
Chlorthalidone [USAN:USP]
Chlorthalidone, European Pharmacopoeia (EP) Reference Standard
Chlorthalidone, United States Pharmacopeia (USP) Reference Standard
Clortalidona
Clortalidona [INN-Spanish]
Clortalidone
Clortalidone [DCIT]
Combipres (Salt/Mix)
CPD000058635
CS-2290
CTK8F8619
D00272
D09NIA
DB00310
DivK1c_000731
DSSTox_CID_2812
DSSTox_GSID_22812
DSSTox_RID_76738
DTXSID4022812
EINECS 201-022-5
Famolin
FT-0602965
G 33182
G-33182
GTPL7147
H530
HE063110
HE387799
Higroton
HMS1569G03
HMS1920M09
HMS2091E12
HMS2096G03
HMS2236D07
HMS3259H04
HMS3372A07
HMS502E13
HSDB 3035
HY-15833
Hydro-Long
Hygroton
Hygroton (TN)
I06-0208
IDI1_000731
Igroton
Isoren
JIVPVXMEBJLZRO-UHFFFAOYSA-N
KB-229744
KBio1_000731
KBio2_000626
KBio2_003194
KBio2_005762
KBio3_001237
KBioGR_001574
KBioSS_000626
KS-00000FWZ
KS-1342
LS-31408
MCULE-6661021422
MFCD00036257
MLS000069531
MolPort-002-736-049
Natriuran
NC00690
NCGC00016317-01
NCGC00094616-01
NCGC00094616-02
NCGC00094616-03
NCGC00094616-04
NCGC00094616-07
NINDS_000731
NSC 69200
NSC-69200
NSC-756692
NSC69200
NSC756692
Oksodolin
Oksodolin (oxodolin)
Opera_ID_138
Oradil
Oxodolin
Oxodoline
Pharmakon1600-01500187
Phthalamodine
Phthalamudine
Prestwick_759
Prestwick0_000351
Prestwick1_000351
Prestwick2_000351
Prestwick3_000351
Racemic chlorthalidone
Regroton (Salt/Mix)
Renon
Saluretin
SAM002589983
SBI-0051313.P003
SCHEMBL26234
SMR000058635
SPBio_000058
SPBio_002362
Spectrum_000146
SPECTRUM1500187
Spectrum2_000099
Spectrum3_000349
Spectrum4_000957
Spectrum5_000743
SR-01000721929
SR-01000721929-2
ST088141
ST2409846
STK686335
Tenoretic
Thalitone (TN)
Tox21_110369
Tox21_110369_1
Urolin
VZ31574
W-104322
Zambesil

US Patents and Regulatory Information for THALITONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc THALITONE chlorthalidone TABLET;ORAL 019574-001 Dec 20, 1988 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Casper Pharma Llc THALITONE chlorthalidone TABLET;ORAL 019574-002 Feb 12, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms THALITONE chlorthalidone TABLET;ORAL 088051-001 Nov 12, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Deloitte
Fish and Richardson
Express Scripts
Cerilliant
Daiichi Sankyo
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.